非心脏性昏迷的基于机制的治疗:一本实用指南
Michele Brignole1, Giulia Rivasi2, Artur Fedorowski3,4
1IRCCS Istituto Auxologico Italiano, Faint and Fall Research Centre, Department of Cardiology, S. Luca Hospital, Piazzale Brescia 20, 20149 Milano, Italy.
非心脏性昏迷的管理需要确定血液动力学机制. 有效的疗法针对的是低血压或心的表型,以防止复发性昏迷.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 内部医学 内部医学
背景情况:
- 非心脏性昏迷包括暂时失去意识,不包括主要心脏原因.
- 反射失眠和静止性低血压是常见的病因.
- 目前的治疗策略缺乏普遍有效性,需要基于机制的方法.
研究的目的:
- 突出识别非心脏性昏迷中的血液动力学机制的重要性.
- 为了区分低血压和心综合症表型.
- 根据昏迷表型指导个性化治疗选择.
主要方法:
- 临床评估以排除心脏.
- 血液动力学表型识别,以区分低血压和心肌压力机制.
- 对针对特定表型的治疗干预措施的审查.
主要成果:
- 非心脏性昏迷的特点是有两个主要的血液动力学现象型:低血压和心性昏迷.
- 治疗疗效是由底层的血液动力学机制决定的,而不仅仅是病因.
- 对于每个表型,特定的治疗方法是有效的:例如,液体管理和血管压缩剂用于低血压,对心脏进行节奏.
结论:
- 非心脏性昏迷的个性化治疗取决于准确的血液动力学表型.
- 准低血压或心肌梗塞对于有效的昏迷管理至关重要.
- 区分昏睡现象类型可以优化治疗策略和预防复发.
更多相关视频
09:52Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
Published on: January 15, 2017
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
相关概念视频
Heart Failure Drugs: Inotropic Agents
Mechanism of Cardiac Arrhythmias
Heart Failure Drugs: β-Blockers
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
